Regarding mitochondrial involvement with neurodegenerative and muscular diseases.

Our cutting-edge technology will transform the treatment of mitochondrial-based neurodegenerative

and muscular diseases by targeting their root cause-mutations in mitochondrial DNA. Through pioneering research, we have developed a novel chemical synthetic pathway enabling the design and development of Mito-DNA target imprecision therapeutics. We empower pharmaceutical innovation with validated

mitochondrial targets, high-fidelity functional assays,

and novel small molecules. Guided by world-class scientific leadership and integrated UK–US teams,

we are unlocking the next generation of mitochondrial medicine to treat smarter and deliver lasting impacts

for patients facing challenging diseases.